Listen
Japanese
Contact

News

Sawai Announces Listing of Two Generic Drugs with Eight Strengths

Jun. 15. 2023

Osaka, Japan – June 15, 2023 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) today announced the listing of two generic drugs with eight strengths in the NHI (National Health Insurance) drug price list. Sawai’s product line now includes 331 compounds with 804 strengths.

The list of new products

1. Azilsartan Tablets, OD Tablets

Generic name Azilsartan
Strengths Tablets: 10mg, 20mg, 40mg
OD Tablets: 10mg, 20mg, 40mg
Brand products AZILVA® Tablets 10mg, 20mg, 40mg

2. Zinc Acetate Tablets

Generic name Zinc Acetate Hydrate
Strengths 25mg, 50mg
Brand products NOBELZIN® Tablets 25mg, 50mg

 

The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.